Cargando…
Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort study
BACKGROUND: To determine the risk-assessment role of the immune-inflammatory biomarkers on myocardial damage in COVID-19 patients with diabetes mellitus (DM). METHODS: This retrospective study was conducted on 822 COVID-19 inpatients from 1 January to 10 March 2020 at Renmin Hospital of Wuhan Univer...
Autores principales: | Bo, Yi, Yuli, Cai, Ye, Wang, Junfeng, Li, Xiaolin, Chen, Yan, Bao, Zhongyuan, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483899/ https://www.ncbi.nlm.nih.gov/pubmed/36123740 http://dx.doi.org/10.1186/s12933-022-01625-2 |
Ejemplares similares
-
Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history
por: Cai, Yuli, et al.
Publicado: (2020) -
Effect of hyperglycemia on the immune function of COVID-19 patients with type 2 diabetes mellitus: a retrospective study
por: Wang, Ye, et al.
Publicado: (2022) -
Inflammatory biomarkers and cardiac injury in COVID-19 patients
por: Mumtaz, Ayesha, et al.
Publicado: (2022) -
Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
por: YI, BO, et al.
Publicado: (2014) -
Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis
por: Cai, Yuli, et al.
Publicado: (2017)